Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1963 1
1965 2
1985 1
1986 2
1987 3
1988 2
1989 1
1990 1
1992 2
1993 3
1994 3
1995 3
1996 1
1998 2
2000 1
2002 1
2003 3
2004 3
2005 1
2006 3
2007 2
2008 3
2009 4
2010 4
2011 2
2012 3
2013 3
2015 2
2016 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Results by year

Filters applied: . Clear all
Page 1
Differential effects of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I are consistent across hypercholesterolemic patient subgroups.
Davidson MH, Ose L, Frohlich J, Scott RS, Dujovne CA, Escobar ID, Bertolami MC, Cihon F, Maccubbin DL, Mercuri M. Davidson MH, et al. Among authors: maccubbin dl. Clin Cardiol. 2003 Nov;26(11):509-14. doi: 10.1002/clc.4960261106. Clin Cardiol. 2003. PMID: 14640465 Free PMC article. Review.
Safety of extended-release niacin/laropiprant in patients with dyslipidemia.
McKenney J, Bays H, Koren M, Ballantyne CM, Paolini JF, Mitchel Y, Betteridge A, Kuznetsova O, Sapre A, Sisk CM, Maccubbin D. McKenney J, et al. Among authors: maccubbin d. J Clin Lipidol. 2010 Mar-Apr;4(2):105-112.e1. doi: 10.1016/j.jacl.2010.02.002. Epub 2010 Feb 12. J Clin Lipidol. 2010. PMID: 21122637 Clinical Trial.
Polymyxin B-mediated lysis of tumor cells.
Verstovsek S, Maccubbin DL, Ehrke MJ, Mihich E. Verstovsek S, et al. Among authors: maccubbin dl. Int Arch Allergy Immunol. 1993;100(1):47-52. doi: 10.1159/000236386. Int Arch Allergy Immunol. 1993. PMID: 8428163
Effectiveness and safety of laropiprant on niacin-induced flushing.
Maccubbin DL, Chen F, Anderson JW, Sirah W, McCrary Sisk C, Kher U, Olsson AG, Bays HE, Mitchel YB. Maccubbin DL, et al. Am J Cardiol. 2012 Sep 15;110(6):817-22. doi: 10.1016/j.amjcard.2012.05.009. Epub 2012 Jun 8. Am J Cardiol. 2012. PMID: 22683042 Clinical Trial.
Striated muscle safety of ezetimibe/simvastatin (Vytorin).
Davidson MH, Maccubbin D, Stepanavage M, Strony J, Musliner T. Davidson MH, et al. Among authors: maccubbin d. Am J Cardiol. 2006 Jan 15;97(2):223-8. doi: 10.1016/j.amjcard.2005.08.038. Epub 2005 Nov 21. Am J Cardiol. 2006. PMID: 16442367
Extended-release niacin/laropiprant significantly improves lipid levels in type 2 diabetes mellitus irrespective of baseline glycemic control.
Bays HE, Brinton EA, Triscari J, Chen E, Maccubbin D, MacLean AA, Gibson KL, Ruck RA, Johnson-Levonas AO, O'Neill EA, Mitchel YB. Bays HE, et al. Among authors: maccubbin d. Vasc Health Risk Manag. 2015 Feb 24;11:165-72. doi: 10.2147/VHRM.S70907. eCollection 2015. Vasc Health Risk Manag. 2015. PMID: 25750540 Free PMC article. Clinical Trial.
62 results